Globus Medical (GMED) Cash from Financing Activities (2011 - 2026)

Globus Medical (GMED) has 16 years of Cash from Financing Activities data on file, last reported at $18.2 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 102.86% year-over-year to $18.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.6 million (up 95.33% YoY) and the FY2025 annual result came in at -$679.2 million, down 2352.2% from the prior year.
• Cash from Financing Activities improved to $18.2 million in Q1 2026, from $13.2 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $59.7 million in Q4 2024 to a low of -$635.4 million in Q1 2025.
• A 5-year average of -$60.6 million and a median of $2.9 million in 2023 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 1428.54% — and 2024, when it plunged 4036.09%.
• Tracing GMED's Cash from Financing Activities over 5 years: stood at $13.6 million in 2022, then tumbled by 1845.79% to -$237.3 million in 2023, then surged by 125.18% to $59.7 million in 2024, then tumbled by 77.88% to $13.2 million in 2025, then soared by 37.7% to $18.2 million in 2026.
• The last three Cash from Financing Activities figures came in at $18.2 million (Q1 2026), $13.2 million (Q4 2025), and -$32.0 million (Q3 2025), per Business Quant data.